Cellectar Biosciences's three largest insider shareholders as of September 09, 2026 are Andrei Shustov (Senior Vice President, Medical, 55.04K shares), Douglas J Swirsky (Director, 25.00K shares), Jarrod Longcor (Chief Operating Officer, 20.45K shares).
| # | Insider | Position | Direct | Indirect | Total | Share of Insiders | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Andrei Shustov | Senior Vice President, Medical | 55,038 | 0 | 55,038 | 43.3% | 12 Dec, 2023 |
| 2 | Douglas J Swirsky | Director | 25,000 | 0 | 25,000 | 19.6% | 14 Sep, 2021 |
| 3 | Jarrod Longcor | Chief Operating Officer | 20,451 | 0 | 20,451 | 16.1% | 11 May, 2026 |
| 4 | James V Caruso | Chief Executive Officer | 20,318 | 0 | 20,318 | 16.0% | 11 May, 2026 |
| 5 | Chad J Kolean | Chief Financial Officer | 6,418 | 0 | 6,418 | 5.0% | 03 Jul, 2025 |
| 6 | John Neis | Director | 0 | 10 | 10 | 0.0% | 16 Dec, 2025 |
Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.
| Date | Insider | Position | Transaction | Shares | Price | Value | Shares Held After | Ownership |
|---|---|---|---|---|---|---|---|---|
| 08 Jul, 2026 | Stefan Loren | Other | Acquired A | 15,000 | $0.00 | $0 | 15,000 | Direct |
| 07 Jul, 2026 | Jarrod Longcor | Chief Operating Officer | Acquired A | 118,000 | $0.00 | $0 | 118,000 | Direct |
| 07 Jul, 2026 | Asher Chanan-Khan | Director | Acquired A | 25,000 | $0.00 | $0 | 25,000 | Direct |
| 07 Jul, 2026 | Chad J Kolean | Cfo | Acquired A | 92,000 | $0.00 | $0 | 92,000 | Direct |
| 07 Jul, 2026 | John Neis | Director | Acquired A | 25,000 | $0.00 | $0 | 25,000 | Direct |
| 07 Jul, 2026 | Douglas J Swirsky | Director | Acquired A | 37,500 | $0.00 | $0 | 37,500 | Direct |
| 08 Jul, 2026 | Stefan Loren | Other | Acquired A | 15,000 | $0.00 | $0 | 15,000 | Direct |
| 07 Jul, 2026 | James V Caruso | President Ceo | Acquired A | 250,000 | $0.00 | $0 | 250,000 | Direct |
| 07 Jul, 2026 | Frederick W Driscoll | Director | Acquired A | 25,000 | $0.00 | $0 | 25,000 | Direct |
| 07 Jul, 2026 | Andrew Gu | Director | Acquired A | 25,000 | $0.00 | $0 | 25,000 | Direct |
| 07 May, 2026 | James V Caruso | Chief Executive Officer | Acquired P | 8,680 | $2.88 | $25.00K | 20,318 | Direct |
| 07 May, 2026 | Jarrod Longcor | Chief Operating Officer | Acquired P | 8,680 | $2.88 | $25.00K | 20,451 | Direct |
| 07 May, 2026 | Jarrod Longcor | Chief Operating Officer | Acquired P | 26,040 | $0.01 | $260 | 36,149 | Direct |
| 07 May, 2026 | James V Caruso | Chief Executive Officer | Acquired P | 26,040 | $0.01 | $260 | 36,076 | Direct |
| 12 Dec, 2025 | John Neis | Director | Disposed S | 198 | $3.70 | $732 | 10 | Indirect |
| 12 Dec, 2025 | John Neis | Director | Disposed S | 198 | $3.70 | $732 | 10 | Indirect |
| 02 Jul, 2025 | Jarrod Longcor | Chief Operating Officer | Acquired P | 10,000 | $4.99 | $49.90K | 12,768 | Direct |
| 02 Jul, 2025 | James V Caruso | Chief Executive Officer | Acquired P | 10,000 | $4.99 | $49.90K | 11,638 | Direct |
| 02 Jul, 2025 | Chad J Kolean | Chief Financial Officer | Acquired P | 5,000 | $4.99 | $24.95K | 6,418 | Direct |
| 02 Jul, 2025 | Chad J Kolean | Chief Financial Officer | Acquired P | 5,000 | $0.01 | $50 | 5,000 | Direct |